Succinate dehydrogenase deficiency in a PDGFRA mutated GIST

BACKGROUND: Most gastrointestinal stromal tumors (GISTs) harbor mutually exclusive gain of function mutations in the receptor tyrosine kinase (RTK) KIT (70–80%) or in the related receptor PDGFRA (~10%). These GISTs generally respond well to therapy with the RTK inhibitor imatinib mesylate (IM), alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Belinsky, Martin G., Cai, Kathy Q., Zhou, Yan, Luo, Biao, Pei, Jianming, Rink, Lori, von Mehren, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541693/
https://www.ncbi.nlm.nih.gov/pubmed/28768491
http://dx.doi.org/10.1186/s12885-017-3499-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541693/
https://www.ncbi.nlm.nih.gov/pubmed/28768491
http://dx.doi.org/10.1186/s12885-017-3499-7

Ejemplares similares